IGMPI facebook News
IGMPI Logo
Institute of Good Manufacturing Practices India

(An Autonomous Body Recognized by Ministry of Commerce & Industry, Government of India)

Competency based placement focussed Education | Training | Research | Consultancy

ADMISSIONS NOTICE
18001031071 (Toll Free), +91 11 26512850
Regular | Part-time (Online Live Classes) Modes
Gain declares positive Phase I results for Parkinson’s therapy
Alto Neuroscience declares positive ALTO-101 Phase I trial results
Cinnamon, curcumin, and resveratrol show potential promise in diabetes inflammation fight
Food additive emulsifiers associated with increased risk of type 2 diabetes
Indian healthcare capitalizes on the adoption of AI & ML in patient rehabilitation
WHO notifies widespread overuse of antibiotics in patients hospitalized with Covid-19
Neurocrine declares positive Phase II trial results for NBI-1065845
Kintor Pharma’s GT20029 Phase II trial meets primary endpoint
NeuroSmart Portable MER system paves way for improved treatments in Parkinson’s disease
Fresenius Medical Care recalls 2M dialysis devices due to toxin exposure risk
Infutronix infusion pump recall associated with 6 injuries, 1 death
Exo received FDA-clearance for AI tools and adds to handheld ultrasound system
Medtronic received FDA approval for Inceptiv closed-loop spinal cord stimulator
Abbott received FDA approval for Esprit resorbable scaffold
Addex Therapeutics: Phase 2 epilepsy study of ADX71149 fails to meet primary endpoint